Cannabidiol (CBD) oil comes from the Cannabis plant and has become a popular alternative therapy for a range of conditions over the past few years. Due to the prohibition of cannabis and associated research restrictions, there are limited evidence from human studies to support the benefits of CBD oil. However, with the legalization of cannabis in some regions around the globe, research in this area is gaining momentum.
Use of the CBD
CBD is just one of many different molecules unique to the Cannabis plant. CBD oil generally contains low levels of the cannabinoid tetrahydrocannabinol (THC), which is the compound that produces the ‘high.’ Generally, most people tolerate CBD is well and experience minimal serious side effects. Unlike THC, CBD does not bind readily to cannabinoid receptors. These receptors are key components of the human endocannabinoid system, which plays a crucial role in the central nervous system. Endocannabinoids are signaling molecules that help regulate various processes, such as pain, memory, mood, immunity, and stress. CBD does, however, interact with other receptors, such as serotonin and opioid receptors. It might also boost levels of naturally occurring endocannabinoids, which may explain its seemingly broad range of uses. Choosing the Pure CBD oil is essential here.
Epilepsy
Scientists need to carry out more research to understand the benefits and risks of CBD oil. The first CBD-based medication that the Food and Drug Administration (FDA) approved was Epidiolex. Doctors prescribe Epidiolex to those who experience seizures due to Lennox-Gastrault or Dravet syndrome, which are rare types of epilepsy. Epidiolex underwent rigorous human studies before the FDA approved it as a treatment for these two conditions. For more information and resources on CBD and CBD products, please visit our dedicated hub.
Pain and inflammation
Researchers have investigated the pain-relieving effects of Pure CBD oil. A small 2020 randomized, placebo-controlled tria investigated the use of topical CBD oil on people with peripheral neuropathy of the legs. In this small study, participants with peripheral noncancer neuropathic pain received either 250 milligrams (mg) of CBD total dissolved in 3 oz of oil) or a placebo. After 4 weeks, the researchers noted a statistically significant reduction in intense pain, sharp pain, cold and itchy sensations in those using CBD oil. Participants did not report any side effects. Although the results of this small trial are positive, it involved just 29 participants, so researchers need to conduct more investigations to confirm the results. You need to keep these in mind while using the same.
